Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.8fepf Regulatory News (SANB)

Share Price Information for Sant Uk.8fepf (SANB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 129.00
Ask: 133.00
Change: 0.00 (0.00%)
Spread: 4.00 (3.101%)
Open: 131.50
High: 131.50
Low: 131.00
Prev. Close: 131.00
SANB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplementary Prospectus

1 Mar 2024 12:11

RNS Number : 2976F
Santander UK Group Holdings PLC
01 March 2024
 

SANTANDER UK GROUP HOLDINGS PLCSANTANDER UK PLC?30,000,000,000 EURO MEDIUM TERM NOTE PROGRAMMEPUBLICATION OF SUPPLEMENTARY PROSPECTUS

 

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Financial Conduct Authority and is available for viewing:

 

Supplementary Prospectus dated 1 March 2024 to the prospectus dated 12 April 2023, as supplemented on 25 April 2023, 26 July 2023, 14 August 2023, 25 October 2023 and 31 January 2024 relating to the ?30,000,000,000 Euro Medium Term Note Programme of Santander UK Group Holdings plc and Santander UK plc (the Prospectus).

 

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/2976F_1-2024-3-1.pdf

 

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Supplementary Prospectus will also be available for viewing via:

 

https://www.santander.co.uk/about-santander/investor-relations/euro-medium-term-note-programme

 

 

For further information, please contact:

 

Medium Term FundingSantander UK plc2 Triton SquareRegent's PlaceLondon NW1 3AN

Email: mtf@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from such Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

 

Your right to access this service is conditional upon your compliance with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPEAADFEEKLEFA
Date   Source Headline
30th Apr 20247:15 amRNSQuarterly Management Statement - Q1 2024
8th Apr 20247:00 amRNSPublication of a Prospectus
3rd Apr 20241:21 pmRNSIssue 1221 and 1222 Early Redemption Notice
18th Mar 20244:51 pmRNSPublication of Final Terms
6th Mar 20248:48 amRNSPublication of a Prospectus
1st Mar 202412:11 pmRNSPublication of Supplementary Prospectus
1st Mar 20247:00 amRNSAnnual Financial Report - 31 December 2023
23rd Feb 20243:36 pmRNSPublication of Final Terms
31st Jan 202412:54 pmRNSPublication of Suppl.Prospcts
31st Jan 202412:49 pmRNSPublication of Suppl.Prospcts
31st Jan 20247:15 amRNSQuarterly Management Statement – Q4 2023
29th Jan 20207:15 amRNSQ4 19 - Quarterly Management Statement
29th Oct 20157:30 amRNS3rd Quarter Results
30th Jul 20157:45 amRNSQuarterly Management Statement - 30 June 2015
30th Sep 20088:57 amRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.